Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies

por Gore, M E, Larkin, J M G
Publicado 2011

Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy

por Vasudev, N S, Goh, V, Juttla, J K, Thompson, V L, Larkin, J M G, Gore, M, Nathan, P D, Reynolds, A R
Publicado 2013

A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

por Larkin, J M G, Hughes, S A, Beirne, D A, Patel, P M, Gibbens, I M, Bate, S C, Thomas, K, Eisen, T G, Gore, M E
Publicado 2007

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

por Larkin, J M G, Ferguson, T R, Pickering, L M, Edmonds, K, James, M G, Thomas, K, Banerji, U, Berns, B, de Boer, C, Gore, M E
Publicado 2010